Allworth Financial’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.1K Buy
523
+274
+110% +$27.6K ﹤0.01% 2443
2026
Q1
$22K Buy
249
+209
+523% +$18K ﹤0.01% 2922
2025
Q4
$3.14K Buy
40
+14
+54% +$1.06K ﹤0.01% 3953
2025
Q3
$1.74K Buy
+26
New +$1.87K ﹤0.01% 4068
2024
Q4
– Sell
-117
Closed -$15.2K – 4012
2024
Q3
$15.2K Hold
117
– – ﹤0.01% 2072
2024
Q2
$12.7K Buy
117
+100
+588% +$10.5K ﹤0.01% 2125
2024
Q1
$1.87K Sell
17
-3
-15% -$302 ﹤0.01% 2831
2023
Q4
$2.1K Buy
20
+14
+233% +$1.36K ﹤0.01% 2665
2023
Q3
$631 Buy
+6
New +$769 ﹤0.01% 2987
2020
Q3
– Sell
-31
Closed -$7K – 1230
2020
Q2
$7K Hold
31
– – ﹤0.01% 800
2020
Q1
$7K Buy
+31
New +$7.65K ﹤0.01% 795

Other funds holding MLAB

Allworth Financial's MLAB Position: Q2 2026 in Review

Allworth Financial increased its Mesa Laboratories (MLAB) stake by 110% in Q2 2026, buying an estimated $27.6K and bringing the position to 523 shares worth $52.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2443.

Allworth Financial first reported a position in MLAB in Q1 2020 and has held it in 11 quarters since. 159 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Allworth Financial held 523 shares of Mesa Laboratories worth $52.1K as of Q2 2026.
  • Allworth Financial bought 274 Mesa Laboratories shares in Q2 2026, an estimated $27.6K.
  • Mesa Laboratories made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2443 holding.
  • Allworth Financial first reported a position in Mesa Laboratories in Q1 2020 and has held it in 11 quarters since.
  • 159 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.